Among 177 carbapenemase-producing Gram-negative bacilli (108 KPC, 32 NDM, 11 IMP, 8 OXA-48, 4 OXA-181, 2 OXA-232, 5 IMI, 4 VIM, and 3 SME producers), aztreonam-avibactam was active against all isolates except two NDM producers with elevated MICs of 8/4 and 16/4 mg/liter; ceftazidime-avibactam was active against all KPC-, IMI-, SME-, and most OXA-48 group-producing isolates (93%) but not metallo-β-lactamase producers. Among older and contemporary antimicrobials, the most active were colistin, tigecycline, and fosfomycin, with overall susceptibilities of 88%, 79%, and 78%, respectively.
In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.
头孢他啶-阿维巴坦、氨曲南-阿维巴坦以及一系列老牌和现代抗菌药物对产碳青霉烯酶革兰氏阴性杆菌的体外活性
阅读:6
作者:Vasoo Shawn, Cunningham Scott A, Cole Nicolynn C, Kohner Peggy C, Menon Sanjay R, Krause Kevin M, Harris Kelly A, De Partha P, Koh Tse Hsien, Patel Robin
| 期刊: | Antimicrobial Agents and Chemotherapy | 影响因子: | 4.500 |
| 时间: | 2015 | 起止号: | 2015 Dec;59(12):7842-6 |
| doi: | 10.1128/AAC.02019-15 | 研究方向: | 微生物学 |
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
